🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 50,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Nanostics lands funding from University of Alberta Innovation Fund

Nanostics lands funding from University of Alberta Innovation Fund
Nanostics lands funding from University of Alberta Innovation Fund

Nanostics, an Edmonton-based precision health company, has secured funding from the University of Alberta Innovation Fund.

The funds will be used to increase the adoption of their ClarityDX Prostate® test in North America, enhancing diagnostic capabilities for prostate cancer.

Led by CEO Dr. John Lewis, Nanostics employs machine learning in its ClarityDX® platform to generate disease risk scores, improving diagnostic accuracy.

"This support will help us promote ClarityDX Prostate among men suspected of prostate cancer," said Dr. Lewis.

Comments